2019
DOI: 10.1016/j.ejmp.2019.09.070
|View full text |Cite
|
Sign up to set email alerts
|

Robustness evaluation of Intensity Modulated Proton Therapy plans using Dose Volume Population Histogram

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…It has, however, two limitations: (i) the error scenarios are fixed and limited in their number while the actual errors follow continuous distributions and (ii) it does not address systematic and random geometrical errors separately, which are different for each treatment and for each fraction. A priori, it remains uncertain how the clinical robustness settings relate to the actual patient errors, and it is not guaranteed that this approach leads to adequate robustness in treatment planning [19][20][21]. Furthermore, it is unclear what is the impact of a VWmin CTV underdose with the current clinical protocol.…”
Section: Introductionmentioning
confidence: 99%
“…It has, however, two limitations: (i) the error scenarios are fixed and limited in their number while the actual errors follow continuous distributions and (ii) it does not address systematic and random geometrical errors separately, which are different for each treatment and for each fraction. A priori, it remains uncertain how the clinical robustness settings relate to the actual patient errors, and it is not guaranteed that this approach leads to adequate robustness in treatment planning [19][20][21]. Furthermore, it is unclear what is the impact of a VWmin CTV underdose with the current clinical protocol.…”
Section: Introductionmentioning
confidence: 99%
“…Intensity-modulated proton therapy (IMPT) is highly sensitive to anatomical variations, which can cause differences between the planned and delivered doses. A result of this can be insufficient target coverage during the course of treatment [1][2][3][4]. An approach to account for these anatomical variations, ensuring adequate target coverage in all treatment fractions while keeping the doses to the OARs acceptable, is to use adaptive treatment planning.…”
Section: Introductionmentioning
confidence: 99%